Kevin Tang

Director · Aurinia Pharmaceuticals

Kevin Tang (Director) filed 9 Form 4 reports in the trailing twelve months (9 purchases, 0 sales), most often in Aurinia Pharmaceuticals Inc. (AUPH). Across 8 priced purchase filings, the average 21-session return was +4.8% from execution and +6.8% from disclosure (delay-adjusted; derived). The largest single filing was $12.7M of AUPH (898,400 sh across 5 lots, as filed), executed Feb 27. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+4.8%

avg across 8 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+6.8%

same 8 filings, from disclosure

Filings, ttm

9 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$28.0M

shares × price, as filed

Last traded

Oct 16

Filed Oct 20

Median ADV $22.3M across their filed names

Impact on $10,000 · 12M

$12,441 (+24.4%)

S&P 500 $10,907 (+9.1%) · 15.3 pts ahead

Kevin Tang S&P 500

Derived: compounded across filings from disclosure dates · past 12 months

Open performance→

Volume by month

Buys $65.1M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names

AUPH

Aurinia Pharmaceuticals Inc. AUPH · 5 buys · 0 sells 5 filings BOLD

Boundless Bio, Inc. BOLD · 5 buys · 0 sells 5 filings FULC

Fulcrum Therapeutics, Inc. FULC · 2 buys · 0 sells 2 filings

Recent filings

BOLDPURCHASE Boundless Bio, Inc. View filing → $277K
118,185 sh × $2.34
Exec Oct 16
Filed Oct 20 · 5:49 PM ET FULCPURCHASE Fulcrum Therapeutics, Inc. View filing → $595K
167,616 sh across 2 lots
Exec Jul 16
Filed Jul 20 · 9:10 PM ET FULCPURCHASE Fulcrum Therapeutics, Inc. View filing → $845K
236,980 sh across 3 lots
Exec Jul 14
Filed Jul 15 · 7:50 PM ET BOLDPURCHASE Boundless Bio, Inc. View filing → $107K
43,878 sh × $2.43
Exec Jul 14
Filed Jul 16 · 8:10 PM ET BOLDPURCHASE Boundless Bio, Inc. View filing → $222K
91,578 sh across 2 lots
Exec Jul 10
Filed Jul 13 · 7:06 PM ET BOLDPURCHASE Boundless Bio, Inc. View filing → $178K
71,612 sh × $2.49
Exec Jul 1
Filed Jul 2 · 7:45 PM ET BOLDPURCHASE Boundless Bio, Inc. View filing → $711K
284,912 sh across 3 lots
Exec Jun 25
Filed Jun 29 · 7:56 PM ET AUPHPURCHASE Aurinia Pharmaceuticals Inc. View filing → $12.4M
812,208 sh across 3 lots
Exec May 29
Filed Jun 2 · 9:54 PM ET More filings →